TP53 and B-cell chronic lymphocytic leukemia: The factors of the CLL-IPI associated with worse outcomes include age >65 years, Rai stages I–IV, presence of del(17p) or mutated TP53, unmutated IGHV status, and serum beta-2 microglobulin > 3.5 mg/L [43].